Are Estring® and Vagifem® Equally Effective and Safe for the Treatment of Urogenital Atrophy in Breast Cancer Patients on Aromatase Inhibitor Therapy?

✍ Scribed by C.E. Simmons; I. Kuchuk; O.C. Freedman; T. Colgan; A. Dodd; K. Kulhanek; J. Sheiner; G. Dranitsaris; M. Dowsett; E. Folkerd; M.J. Clemons

• Book ID: 119219089
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 116 KB
• Volume: 24
• Category: Article
• ISSN: 1433-2981
• DOI: 10.1016/j.clon.2012.06.009